Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Biliary Complications
NCT07715500 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-07-20
Summary
Living donor liver transplantation is widely accepted as an life-saving treatment for patients with end-stage liver diseases. Careful donor selection is essential to maximize the success and minimize the risk of postoperative complications in donors and recipients. Mapping of biliary anatomy is one of the critical assessments for donor selection and surgical planning ,Biliary reconstruction is considered as the "Achilles heel" of liver transplantation and adequate imaging assessment of biliary anatomy can largely benefit the biliary anastomosis. Preoperative imaging assessment of biliary anatomy is good for the selection of donors but may not indispensable for surgical planning and Intraoperative confirmative assessment of biliary anatomy with IOC was essential
Conditions
- Chronic Liver Disease and Cirrhosis
- Liver Transplant; Complications
- Donor Hepatectomy
Interventions
- DIAGNOSTIC_TEST
-
Magnetic Resonance Cholangiopancreatography
Magnetic Resonance Cholangiopancreatography is being excluded from list of Investigation as part of Non inferiority trial
Sponsors & Collaborators
-
Institute of Liver and Biliary Sciences, India
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-01
- Primary Completion
- 2026-07-15
- Completion
- 2026-08-30
Countries
- India
Study Locations
More Related Trials
-
Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver Transplantation
NCT04252794 ·Status: COMPLETED ·Phase: NA
-
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)
NCT07131540 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Orthotopic Liver Transplantation Using a Living Donor
NCT00152607 ·Status: TERMINATED ·Phase: PHASE4
-
Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue
NCT07102550 ·Status: RECRUITING ·Phase: PHASE2
-
The Favorable Impact of HBcAb Positive Grafts on Liver Transplantation for HBV-related HCC
NCT06787534 ·Status: COMPLETED
-
Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool
NCT06088758 ·Status: RECRUITING ·Phase: NA
-
Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant Injury
NCT07362745 ·Status: COMPLETED
-
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial
NCT07075315 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Hepatitis B Virus Reactivation: a Cautionary Event After Liver Transplantation for Patients With Hepatocellular Carcinoma
NCT06114251 ·Status: COMPLETED
-
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial
NCT07131306 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis
NCT04806581 ·Status: UNKNOWN ·Phase: PHASE1
-
Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis
NCT01483248 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis
NCT03529136 ·Status: UNKNOWN ·Phase: PHASE2
-
Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis
NCT01220492 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis
NCT01877759 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Outcomes and Risk Factors for Liver Transplantation Using Significant Fibrotic Grafts
NCT07101718 ·Status: COMPLETED
-
Magnetic Spiderman for Preparation of Liver Donation
NCT04182256 ·Status: COMPLETED ·Phase: NA
-
To Assess the Efficacy of High-Volume Plasma Exchange and GCSF Versus GCSF Alone in Patients of Acute on Chronic Liver Failure (ACLF).
NCT03162419 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis
NCT01724697 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis
NCT07413549 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Rapid Assessment of Donor Liver Quality
NCT03647059 ·Status: UNKNOWN
-
Autologous Bone Marrow Stem Cells in Cirrhosis Patients
NCT00713934 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Adequacy of Trans-jugular Liver Biopsy in Patients With Liver Disease: SAFE-TJLB Study
NCT06469489 ·Status: RECRUITING
-
Study of Mediators of Post Hepatectomy Liver Regeneration
NCT02077062 ·Status: TERMINATED
-
Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis
NCT01728727 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2